rs3762272
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000298.6(PKLR):c.1437-49G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0557 in 1,563,796 control chromosomes in the GnomAD database, including 15,901 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.059 ( 1605 hom., cov: 31)
Exomes 𝑓: 0.055 ( 14296 hom. )
Consequence
PKLR
NM_000298.6 intron
NM_000298.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.700
Genes affected
PKLR (HGNC:9020): (pyruvate kinase L/R) The protein encoded by this gene is a pyruvate kinase that catalyzes the transphosphorylation of phohsphoenolpyruvate into pyruvate and ATP, which is the rate-limiting step of glycolysis. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-155291986-C-T is Benign according to our data. Variant chr1-155291986-C-T is described in ClinVar as [Benign]. Clinvar id is 1252339.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-155291986-C-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.664 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0592 AC: 9006AN: 152006Hom.: 1598 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
9006
AN:
152006
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.131 AC: 31789AN: 242168 AF XY: 0.124 show subpopulations
GnomAD2 exomes
AF:
AC:
31789
AN:
242168
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0554 AC: 78154AN: 1411672Hom.: 14296 Cov.: 23 AF XY: 0.0581 AC XY: 40987AN XY: 704972 show subpopulations
GnomAD4 exome
AF:
AC:
78154
AN:
1411672
Hom.:
Cov.:
23
AF XY:
AC XY:
40987
AN XY:
704972
Gnomad4 AFR exome
AF:
AC:
251
AN:
32418
Gnomad4 AMR exome
AF:
AC:
12081
AN:
44182
Gnomad4 ASJ exome
AF:
AC:
1048
AN:
25844
Gnomad4 EAS exome
AF:
AC:
27887
AN:
39400
Gnomad4 SAS exome
AF:
AC:
16340
AN:
85084
Gnomad4 FIN exome
AF:
AC:
3031
AN:
52906
Gnomad4 NFE exome
AF:
AC:
13527
AN:
1069164
Gnomad4 Remaining exome
AF:
AC:
3926
AN:
58576
Heterozygous variant carriers
0
2813
5627
8440
11254
14067
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1074
2148
3222
4296
5370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0592 AC: 9013AN: 152124Hom.: 1605 Cov.: 31 AF XY: 0.0686 AC XY: 5103AN XY: 74372 show subpopulations
GnomAD4 genome
AF:
AC:
9013
AN:
152124
Hom.:
Cov.:
31
AF XY:
AC XY:
5103
AN XY:
74372
Gnomad4 AFR
AF:
AC:
0.00901118
AN:
0.00901118
Gnomad4 AMR
AF:
AC:
0.145476
AN:
0.145476
Gnomad4 ASJ
AF:
AC:
0.0394813
AN:
0.0394813
Gnomad4 EAS
AF:
AC:
0.682364
AN:
0.682364
Gnomad4 SAS
AF:
AC:
0.213367
AN:
0.213367
Gnomad4 FIN
AF:
AC:
0.0627358
AN:
0.0627358
Gnomad4 NFE
AF:
AC:
0.0135179
AN:
0.0135179
Gnomad4 OTH
AF:
AC:
0.0554502
AN:
0.0554502
Heterozygous variant carriers
0
291
582
873
1164
1455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1334
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at